ADIPOQ and early-onset autosomal dominant Alzheimer disease: In contrast to the pro-Alzheimer’s disease effects of increased adiponectin levels, physiologic adiponectin levels reduced beta-amyloid toxicity in human neuroblastoma cells [41], suggesting a dose-response relationship and the possible importance of the leptin/adiponectin ratio in pathogenic processes.